Has Pavan Reddy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $68,936 in general payments to Pavan Reddy, MD across 679 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Pavan Reddy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Pavan Reddy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Pavan Reddy, MD

Hematology & Oncology · Wichita, KSNPI 1932161155

Payments from drug & device makers

$68,936in general payments, 2019–2025

Across 679 payments — averaging $101.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Jazz Pharmaceuticals Inc.$12K
EMD Serono, Inc.$12K
AstraZeneca$10K
Daiichi Sankyo Inc.$7K
Merck$4K
Boehringer Ingelheim$4K
plus $19K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Jazz Pharmaceuticals Inc.	8	$12,324
EMD Serono, Inc.	30	$12,239
AstraZeneca(2 entities)	24	$10,073
Daiichi Sankyo Inc.	22	$6,796
Merck	85	$4,490
Boehringer Ingelheim	2	$3,569
Bristol Myers Squibb	46	$2,598
E.r. Squibb & Sons, L.L.C.	60	$2,223
Taiho Oncology, Inc.	3	$1,432
Geron Corporation	1	$1,200
Pfizer	82	$1,170
Verastem, Inc.	3	$1,144
Novartis	51	$1,057
Dova Pharmaceuticals	3	$1,004
Rigel Pharmaceuticals, Inc.	6	$932
Karyopharm Therapeutics Inc.	4	$799
Genentech USA, Inc.	11	$514
Verity Pharmaceuticals Inc.	1	$500
Astellas Pharma US Inc	9	$422
Amgen	27	$408
Johnson & Johnson	19	$407
AbbVie	24	$392
Seagen Inc.	15	$373
Takeda Pharmaceuticals U.S.A., Inc.	12	$270
Eisai Inc.	6	$210
Gilead(2 entities)	12	$171
Puma Biotechnology, Inc.	4	$162
Pharmacyclics LLC, An Abbvie Company	9	$154
Array Biopharma Inc	3	$149
GSK	9	$144
Epizyme, Inc.	8	$141
Lilly USA, LLC	8	$127
Sanofi	7	$125
Intuitive Surgical	1	$118
Incyte Corporation	5	$84
US Oncology Corporate, Inc.	1	$70
Servier Pharmaceuticals LLC	4	$66
Acrotech Biopharma Inc.	4	$64
Springworks Therapeutics, Inc.	4	$62
Lexicon Pharmaceuticals, Inc.	2	$59
Beigene USA, Inc.	4	$50
Genmab U.S., Inc.	3	$47
Sobi, Inc	3	$46
Tersera Therapeutics LLC	3	$45
Deciphera Pharmaceuticals Inc.	2	$40
Pharmacosmos Therapeutics Inc.	2	$37
Exelixis Inc.	2	$34
Immunocore Limited	2	$32
Clovis Oncology, Inc.	2	$27
Bayer	2	$26
Aurobindo Pharma USA, Inc.	2	$25
Mirati Therapeutics, Inc.	1	$23
Adaptive Biotechnologies Corporation	1	$21
Syndax Pharmaceuticals, Inc.	1	$20
Abbott	1	$20
Recor Medical Inc	1	$20
Legend Biotech USA Inc.	1	$19
Apellis Pharmaceuticals, Inc.	1	$19
Secura Bio, Inc.	1	$18
Spectrum Pharmaceuticals Inc.	1	$17

How this compares

$68,936 in reported general payments places this provider in the 70th percentile of 97 hematology & oncology providers in Kansas.

See all hematology & oncology providers in Kansas →

Medicare billing

Part B allowed, 2024

$12,887,737

Medicare patients

1,908

Services billed

571,786

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Wichita

Shaker DakhilWichita$11.2M
Bassam MattarWichita$1.9M
Quoc TruongWichita$539K
Christopher DakhilWichita$114K
Phu TruongWichita$73K
Nassim NabboutWichita$29K
Jeremy DeutschWichita$28K
Dennis MooreWichita$26K
Seth PageWichita$19K
Priyanka SharmaWestwood$18.5M

See the full list for Kansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →